ETON
ETON
NASDAQ · Pharmaceuticals

Eton Pharmaceuticals Inc

$55.71
-1.38 (-2.42%)
As of Sep 23, 2:50 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target -78.6% upside
Low Target $8.04
Average Target $11.93
High Target $13.91
Current Price $55.71
Current
$55.71
Target
$11.93
$8.04 $11.93 avg $13.91
Scenario Analysis
Bear Case
$8.04
-85.6%
Low target
Base Case
$11.93
-78.6%
Avg target
Bull Case
$13.91
+-75.0%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$66.37
-16.1% from high
52-Week Low
$14.27
+290.4% from low
Target vs 52W High
$11.93
-82.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +15.6%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +7.6%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +20.3%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +185.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -37.1%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +193.1%